Glass House BrandsGLASF -0.80%44 PS Ratio is 5.98 as of Jun. 26, 2026, which is 136% above its 10-year median of 2.53. GuruFocus rates GLASF with a GF Score™ of 44/100 and a GF Value™ of $6.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 953 Drug Manufacturers companies, Glass House Brands ranks worse than 78.28% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Glass House Brands's share price is $12.638.
Glass House Brands's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.11. Hence, Glass House Brands's PS Ratio for today is 5.98.
Warning Sign:
Glass House Brands Inc stock PS Ratio (=6.01) is close to 5-year high of 6.53.
The historical rank and industry rank for Glass House Brands's PS Ratio or its related term are showing as below:
GLASF'
s PS Ratio Range Over the Past 10 Years
Min: 1.31 Med: 2.53 Max: 6.53
Current: 5.96
During the past 6 years, Glass House Brands's highest PS Ratio was 6.53. The lowest was 1.31. And the median was 2.53.
GLASF's PS Ratio is ranked worse than 78.28% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.2
vs GLASF: 5.96
Glass House Brands Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Glass House Brands was -23.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 18.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 5.90% per year.
During the past 6 years, Glass House Brands's highest 3-Year average Revenue per Share Growth Rate was 19.40% per year. The lowest was -0.50% per year. And the median was 18.90% per year.
Back to Basics: PS Ratio
Glass House Brands (OTCPK:GLASF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Glass House Brands PS Ratio Related Terms
Glass House Brands PS Ratio Historical Data
* Premium members only.
The historical data trend for Glass House Brands's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's PS Ratio distribution charts can be found below:
* The bar in red indicates where Glass House Brands's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Glass House Brands's Share Price of today is $12.638. Glass House Brands's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Glass House Brands (GLASF) has a PS Ratio of 5.98 as of Jun. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Glass House Brands and its competitors. This is 136% above median its historical median of 2.53. Over the past decade, Glass House Brands' PS Ratio has ranged from 1.31 to 6.53. According to the industry distribution chart, Glass House Brands ranks #746 out of 953 companies in the Drug Manufacturers industry, placing it in the top 78.3%.
Is Glass House Brands' PS Ratio too high?
Glass House Brands' current PS Ratio of 5.98 is 136% above median its 10-year median of 2.53. Over the past 10 years, this metric has ranged from a low of 1.31 to a high of 6.53. The Drug Manufacturers industry median PS Ratio is 2.20. Glass House Brands' value of 5.98 is 171.8% above this industry median. Based on the distribution chart, Glass House Brands ranks #746 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #746 out of 953 companies for PS Ratio. This places Glass House Brands in the lower half of its industry. The industry median PS Ratio is 2.20. Glass House Brands' value of 5.98 is 171.8% above this benchmark. Historically, Glass House Brands' own PS Ratio has ranged from 1.31 to 6.53 over the past decade. While the company's 10-year median is 2.53 vs. the industry median of 2.20, Glass House Brands has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.20, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current PS Ratio of 5.98 is 171.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Glass House Brands and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current PS Ratio is 5.98, which is 136% above median its own 10-year median of 2.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLASF) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.15, compared to a current price of $12.64 — trading 105.5% above its estimated fair value. The current PS Ratio is 5.98, which is 136% above median its 10-year median of 2.53 and 171.8% above the Drug Manufacturers industry median of 2.20. Glass House Brands' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Glass House Brands (GLASF), the current PS Ratio is 5.98 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLASF) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $12.64 is trading 105.5% above its estimated GF Value™ of $6.15.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLASF:
PS Ratio: 5.98 (136% above median its 10-year median of 2.53)
GF Value™: $6.15 vs. price of $12.64 (105.5% above fair value)
Industry Position: 171.8% above the Drug Manufacturers median (#746 of 953)
No single metric tells the full story. See the GLASF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score
Get the complete analysis for GLASF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLASF has been successfully added to your 
